TP53 and adrenal cortex carcinoma: P53 was predominantly found to be specific for diagnosing ACC (specificity 100%), but not sensitive (17.6%), as either overexpression or global loss of TP53 expression is only seen in 20–25% of ACCs [10,58,84,94].